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Genotype and Phenotype Correlation in Patients with Comorbid Epilepsy and Intellectual Disability
Mohamed Taha, Jill Clayton-Smith

Mentor: Jill Clayton-Smith
Program: Neurology
Epilepsy and intellectual disability
comorbidity is a common condition with
great medical and psychological impact on a
patient’s life and their family members.
We sought to investigate the genotype and
phenotype of patients with epilepsy and
intellectual disability comorbidity who had
negative karyotyping and microarrays results,
to find any statistical correlations of positive
findings with specific clinical features, and
to calculate the diagnostic rates of targeted
exome sequencing panel and whole exome
sequencing.

In 80 patients with the comorbid condition,
recruited by the Manchester Centre of
Genomic Medicine, we analyzed the relevant
clinical information, collected data from 76
patients who were tested by a targeted exome
sequencing panel assembled to diagnose this
condition, and gathered the data of 16 patients
who subsequently went on to be tested by
whole exome sequencing.
The overall detection rate of pathogenic
and likely pathogenic variants in genes
associated with epilepsy and intellectual
disability comorbidity was 24%. There was
a 17% detection rate by the targeted exome
sequencing panel (13/76), and 33% by whole
exome sequencing (5/15). There was no
significant statistical correlation identified

between genotype and phenotype variables.
The STXBP1 gene was the gene most
frequently identified to carry a disease causing
variant, seen in 5 patients.
This study demonstrated the considerable
utility of the use of targeted exome sequencing
as well as whole exome sequencing in this
condition for detection of causative genetic
variants. The absence of statistical correlation
between the chances of finding a pathogenic
result and a specific phenotype, suggests that
the clinical presentations within this group
are not always distinctive or that the use of a
much larger study group is needed to improve
the statistical power. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.020
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Background: There are conflicting reports
on the validity of the multi-biomarker disease
activity (MBDA) score to assess rheumatoid
arthritis (RA) disease activity. We performed a
systematic review of the MBDA and metaanalysis of the correlation between the MBDA
and other RA disease activity measures.
Methods: A systematic review was
performed, searching MEDLINE, EMBASE,
Scopus, Google Scholar, and the Cochrane
Library from inception to March 7, 2017.
Study details, MBDA performance, and

study quality were assessed by independent
reviewers. Correlations of the MBDA with
composite RA disease activity measures were
pooled using random-effects meta-analyses.
Results: Twenty-two studies were identified
in the systematic review, of which 8 (n=3,242
assays) reported correlations of the MBDA
with RA disease activity measures. Pooling
results from these eight studies in the metaanalysis, the MBDA demonstrated modest
correlations with DAS28-CRP (r = 0.41, 95%
CI 0.36-0.46) and DAS28-ESR (r = 0.48,
95% CI 0.38-0.58) with weaker correlations
observed with SDAI (r = 0.35, 95% CI 0.260.43), CDAI (r = 0.26, 95% CI 0.19-0.33),

and RAPID3 (r = 0.23, 95% CI 0.19-0.27).
Correlations between change in MBDA and
change in disease activity measures ranged
from r = 0.53 (DAS28-ESR) to r = 0.26
(CDAI).
Conclusion: The MBDA demonstrates
moderate convergent validity with DAS28CRP and DAS28-ESR, but weaker
correlations with SDAI, CDAI, and RAPID3.
While it appears to complement existing RA
disease activity measures, further assessment
of the MBDA’s performance characteristics is
warranted. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.021
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Hantavirus Cardiopulmonary Syndrome
(HCPS) is a relatively uncommon zoonotic
viral illness classically associated with the
southwestern United States. It is important for
clinicians to include HCPS on the differential
for diffuse alveolar hemorrhage (DAH) and
acute respiratory distress syndrome (ARDS),
as HCPS carries a high mortality rate and
commonly goes unrecognized.
A middle-aged patient presented with fever
and cough and was found to be hypotensive
and thrombocytopenia. Despite being started
on broad spectrum antibiotics, the patient’s
respiratory status rapidly declined, requiring
intubation and ICU level of care. Chest
radiographs revealed diffuse pulmonary
41

infiltrates and computed tomography of the
chest revealed severe bilateral pulmonary
consolidation and edema resembling ARDS.
A bronchoalveolar lavage revealed diffuse
alveolar hemorrhage. All infectious and
rheumatologic workup was negative except
for a significantly elevated Hantavirus IgM
which was reflexed to a state public health
laboratory. In the United States, HCPS is
most commonly caused by the Sin Nombre
virus (SNV), a member of the Hantavirus
genus transmitted primarily by the deer
mouse. This host has an extensive habitat
across much of North America but the
majority of confirmed HCPS cases occur in
the Southwestern U.S. All clinically important
Hantaviruses are transmitted by aerosolized
droplets from urine, feces or saliva of rodents.
The cardiopulmonary phase of HCPS is

Poster Presentation Winners

characterized by capillary leak into the
alveoli, causing bilateral diffuse interstitial
edema and pulmonary hemorrhage that
may resemble ARDS on imaging. Patients
with suspected HCPS should be screened
for Hantavirus IgM and IgG. Positive IgM
samples from U.S. residents are sent to a
Public Health Laboratory for SNV-specific
antibody testing. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.022

Graduate Medical Education Research Journal

